Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL10896513 | 1.00 | — | — | |
| Water SCHEMBL8587972 | 1.00 | — | — | |
| Water SCHEMBL21333 | 1.00 | — | — | |
| Water SCHEMBL78471 | 1.00 | — | — | |
| Water SCHEMBL37908 | 1.00 | — | — | |
| Water SCHEMBL80313 | 1.00 | — | — | |
| SCHEMBL1408311 | 0.95 | — | — | |
| Water SCHEMBL6226530 | 0.95 | LMNA (0.30) | — | |
| Water SCHEMBL3651763 | 0.95 | LMNA (0.30) | — | |
| Water SCHEMBL61018 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008077108-A1 | OPHTHALMIC AND CONTACT LENS SOLUTIONS WITH A PEROXIDE SOURCE AND A PRESERVATIVE | FXS VENTURES, LLC (US) | 2008-06-26 | — | — | WO | claimed |
| US-20070098813-A1 | OPHTHALMIC AND CONTACT LENS SOLUTIONS WITH A PEROXIDE SOURCE AND A PRESERVATIVE | FXS VENTURES, LLC | 2007-05-03 | — | — | US | claimed |
| US-20060078626-A1 | Opthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative | BIOCONCEPT LABORATORIES | 2006-04-13 | — | — | US | claimed |
| EP-1337262-A4 | IMPROVED OPHTHALMIC AND CONTACT LENS SOLUTIONS WITH A PEROXIDE SOURCE AND A CATIONIC POLYMERIC PRESERVATIVE | BIO CONCEPT LAB (US) | 2006-02-08 | — | — | EP | claimed |
| EP-1337262-A2 | IMPROVED OPHTHALMIC AND CONTACT LENS SOLUTIONS WITH A PEROXIDE SOURCE AND A CATIONIC POLYMERIC PRESERVATIVE | Bio-Concept Laboratories (US) | 2003-08-27 | — | — | EP | claimed |
| WO-2002040062-A2 | IMPROVED OPHTHALMIC AND CONTACT LENS SOLUTIONS WITH A PEROXIDE SOURCE AND A CATIONIC POLYMERIC PRESERVATIVE | BIO-CONCEPT LABORATORIES (US) | 2002-05-23 | — | — | WO | claimed |
| US-5807585-A | FOR CONTACT LENSES; CONTAINING HYDROGEN PEROXIDE | CIBA VISION CORPORATION (US) | 1998-09-15 | — | — | US | claimed |
| EP-0354186-B1 | A method of preserving ophthalmic solutions and compositions therefor | CIBA GEIGY AG (CH) | 1996-08-28 | — | — | EP | claimed |
| EP-0706802-A2 | A method of preserving ophthalmic solutions and compositions therefor | CIBA-GEIGY AG (CH) | 1996-04-17 | — | — | EP | claimed |
| EP-0354186-A1 | A method of preserving ophthalmic solutions and compositions therefor | CIBA-GEIGY AG (CH) | 1990-02-07 | — | — | EP | claimed |
| CN-115448341-B | Preparation method of flaky beta alumina | 广西大学 | 2024-06-11 | — | — | CN | disclosed |
| US-20200289699-A1 | L-HISTIDINE AND VITAMIN B IN OPHTHALMIC SOLUTIONS | FXS VENTURES, LLC | 2020-09-17 | — | — | US | disclosed |
| US-20200069576-A1 | COMPOSITIONS CONTAINING ALPHA-2-ADRENERGIC AGONIST COMPONENTS | ALLERGAN INC (US) | 2020-03-05 | — | — | US | disclosed |
| US-10307368-B2 | Compositions containing alpha-2-adrenergic agonist components | ALLERGAN, INC. (US) | 2019-06-04 | — | — | US | disclosed |
| US-20180021254-A1 | COMPOSITIONS CONTAINING ALPHA-2-ADRENERGIC AGONIST COMPONENTS | ALLERGAN INC (US) | 2018-01-25 | — | — | US | disclosed |
| EP-0354186-B1 | A method of preserving ophthalmic solutions and compositions therefor | CIBA GEIGY AG (CH) | 1996-08-28 | — | — | EP | disclosed |
| EP-0706802-A2 | A method of preserving ophthalmic solutions and compositions therefor | CIBA-GEIGY AG (CH) | 1996-04-17 | — | — | EP | disclosed |
| EP-0698081-A1 | PROCESS FOR CONSOLIDATING PARTICULATE SOLIDS AND CLEANING PRODUCTS THEREFROM | Henkel-Ecolab GmbH & Co. OHG (DE) | 1996-02-28 | — | — | EP | disclosed |
| WO-1994025563-A1 | PROCESS FOR CONSOLIDATING PARTICULATE SOLIDS AND CLEANING PRODUCTS THEREFROM | HENKEL-ECOLAB GMBH & CO. OHG (DE) | 1994-11-10 | — | — | WO | disclosed |
| EP-0354186-A1 | A method of preserving ophthalmic solutions and compositions therefor | CIBA-GEIGY AG (CH) | 1990-02-07 | — | — | EP | disclosed |